Abstract:We investigated the feasibility of radioiodine therapy targeting hepatoma cells (MH3924A) by tissue-specific expression of the human sodium/iodide symporter (hNIS) gene directed by the murine albumin enhancer and promoter (mAlb). Methods: The cell-specific transcriptional activity of mAlb was examined by a luciferase assay in several transiently transfected cell lines. MH3924A cells were stably transfected with the recombinant retroviral vector, in which hNIS complementary DNA expression was driven by mAlb and coupled to hygromycin resistance gene using an internal ribosomal entry site (IRES). Functional hNIS expression in hepatoma cells was confirmed by an iodide uptake assay. In imaging studies, the tumor-bearing ACl rats were intravenously injected with I-131 and imaged with a gamma-camera. Biodistribution was studied at 30 min and at 1, 3, 6, and 25 h after injection of I-131. Toxic effects of I-131 on hepatoma cells were studied in vitro and in vivo. Results: Stably transfected MH3924A cells concentrated I-125 up to 240-fold higher than the wild-type cells. The iodide uptake in stably transfected cells was inhibited by ouabain and sodium perchlorate but increased by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid. An in vitro clonogenic assay revealed an 86% decrease in colony number in stably transfected cells after exposure to 3.7 MBq/mL of I-131 and only about 8% in hNIS-negative control cells. Furthermore, the in vivo study showed intense tracer accumulation in hNIS-expressing tumors after administration of I-131. At 3 h after intraperitoneal injection, the transfected tumors accumulated I-131 19.2-fold higher than the parental tumors in a biodistribution study. Moreover, administration of a therapeutic dose of I-131 resulted in an inhibition of hNIS-expressing tumor growth, whereas control tumors continued to increase in size. Conclusion: A therapeutic effect of I-131 on hepatoma cells in vitro and in vivo has been demonstrated after tumor-specific iodide uptake induced by mAlb-directed hNIS gene expression. Because a stable transformed cell line has been used in these experiments, the clinical potential of this strategy must be evaluated after in vivo transfection of hepatoma cells.

Experimental study of tumor targeted therapy with sodium iodide symporter gene regulated by human telomerase reverse transcriptase promoter

Experimental Study of Dual Promoter Baculovirus-Mediated Tumor-Targeting Radioiodine Therapy

Use of Rhenium-188 for in Vivo Imaging and Treatment of Human Cervical Cancer Cells Transfected with Lentivirus Expressing Sodium Iodide Symporter.

Transfer of Human Sodium/iodide Symporter Gene Induces Iodide Uptake in Melanoma Cells

Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two-and three-dimensional models

Efficient Multicistronic Co-Expression of Hnis and Htpo in Prostate Cancer Cells for Nonthyroidal Tumor Radioiodine Therapy.

Radioiodide Uptake in Melanoma Cells after Transfer of Human NaI Symporter Gene

Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using 188re: a Human Glioma Study in Mice.

Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells

Radioiodine Therapy of Hepatoma Using Targeted Transfer of the Human Sodium/Iodide Symporter Gene

Study on the Transfer of the Rhnis Gene into Human Bile Duct Carcinoma Cells to Induce125i Uptake

99Mtc-Pertechnetate Uptake in Hepatoma Cells Due to Tissue-Specific Human Sodium Iodide Symporter Gene Expression

In Vivo Molecular Imaging And Radionuclide (I-131) Therapy Of Human Nasopharyngeal Carcinoma Cells Transfected With A Lentivirus Expressing Sodium Iodide Symporter

Experimental Study of Baculovirus-Mediated Transfer of the Thyroid Sodium/iodide Symporter Gene into Thyroid Cancer for Targeted Radiotherapy

Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.

Preliminary Studies of Human Sodium Iodide Symporter Gene Imaging and Therapy Through 188re: A Human Glioma Study in Model Mice

Human Sodium/Iodide Symporter Gene Induced Iodine Uptake in Human Lung Adenocarcinoma Via Baculovirus

In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter

NES1/KLK10 and Hnis Gene Therapy Enhanced Iodine-131 Internal Radiation in PC3 Proliferation Inhibition

Preparation of a Recombinant Adeno-Associated Virus Vector Encoding the Human NIS Gene and Its Expression in Thyroid Cancer Cell Lines

Human Sodium Iodide Transporter Gene-Mediated Imaging and Therapy of Mouse Glioma, Comparison Between 188re and 131I.